Wu J - Search Results

1

Risk of fatigue in cancer patients receiving anti-EGFR monoclonal antibodies: results from a systematic review and meta-analysis of randomized controlled trial.

Zhu J, Zhao W, Liang D, Li G, Qiu K, Wu J, Li J. Zhu J, et al. Among authors: wu j. Int J Clin Oncol. 2018 Apr;23(2):389-399. doi: 10.1007/s10147-017-1218-7. Epub 2017 Nov 27. Int J Clin Oncol. 2018. PMID: 29181651

2

Meta-analysis of randomized controlled trials for the incidence and risk of treatment-related mortality in patients with breast cancer treated with HER2 blockade.

Wu J, Qiu K, Zhu J, Li J, Lin Y, He Z, Li G. Wu J, et al. Breast. 2015 Dec;24(6):699-704. doi: 10.1016/j.breast.2015.08.006. Epub 2015 Sep 12. Breast. 2015. PMID: 26376461

3

Amphiphilic Copolymeric Micelles for Doxorubicin and Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer.

Lv L, Qiu K, Yu X, Chen C, Qin F, Shi Y, Ou J, Zhang T, Zhu H, Wu J, Liu C, Li G. Lv L, et al. Among authors: wu j. J Biomed Nanotechnol. 2016 May;12(5):973-85. doi: 10.1166/jbn.2016.2231. J Biomed Nanotechnol. 2016. PMID: 27305819

4

Meta-analysis of randomized controlled trials for the incidence and risk of fatal adverse events in cancer patients treated with ipilimumab.

Zhu J, Wu J, Li G, Li J, Lin Y, He Z, Su C, Zhao W, Wu Q, Chen Z, Qiu K. Zhu J, et al. Among authors: wu q, wu j. Expert Opin Drug Saf. 2017 Apr;16(4):423-428. doi: 10.1080/14740338.2017.1297420. Epub 2017 Feb 24. Expert Opin Drug Saf. 2017. PMID: 28276859

5

Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy.

Rao N, Qiu J, Wu J, Zeng H, Su F, Qiu K, Wu J, Yao H. Rao N, et al. Among authors: wu j. Chemotherapy. 2017;62(4):246-255. doi: 10.1159/000470900. Epub 2017 May 5. Chemotherapy. 2017. PMID: 28472798

6

Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma.

Wu J, Qiu K, Zhu J. Wu J, et al. Lancet Oncol. 2017 May;18(5):e241-e242. doi: 10.1016/S1470-2045(17)30262-0. Lancet Oncol. 2017. PMID: 28495287 No abstract available.

7

Toxicity profile characteristics of novel androgen-deprivation therapy agents in patients with prostate cancer: a meta-analysis.

Zhu J, Liao R, Su C, Liang D, Wu J, Qiu K, Li J. Zhu J, et al. Among authors: wu j. Expert Rev Anticancer Ther. 2018 Feb;18(2):193-198. doi: 10.1080/14737140.2018.1419871. Epub 2017 Dec 26. Expert Rev Anticancer Ther. 2018. PMID: 29257709

8

Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis.

Zheng Y, Zhu J, Liu Y, Lai W, Lin C, Qiu K, Wu J, Yao W. Zheng Y, et al. Among authors: wu j. BMJ. 2018 Nov 6;363:k4388. doi: 10.1136/bmj.k4388. BMJ. 2018. PMID: 30401700 Free PMC article.

9

Risk of adverse events in lymphoma patients treated with brentuximab vedotin: a systematic review and meta-analysis.

Gao S, Zhang M, Wu K, Zhu J, He Z, Li J, Chen C, Qiu K, Yu X, Wu J. Gao S, et al. Among authors: wu k, wu j. Expert Opin Drug Saf. 2020 May;19(5):617-623. doi: 10.1080/14740338.2020.1718103. Epub 2020 Jan 24. Expert Opin Drug Saf. 2020. PMID: 31955620

10

Association of glucose-lowering medications with cardiovascular outcomes: an umbrella review and evidence map.

Zhu J, Yu X, Zheng Y, Li J, Wang Y, Lin Y, He Z, Zhao W, Chen C, Qiu K, Wu J. Zhu J, et al. Among authors: wu j. Lancet Diabetes Endocrinol. 2020 Mar;8(3):192-205. doi: 10.1016/S2213-8587(19)30422-X. Epub 2020 Jan 29. Lancet Diabetes Endocrinol. 2020. PMID: 32006518

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77,879 results

Search Page

Filters